MedPath

A randomised controlled trial of the effect of a practice-based genetic screening facilitator.

Completed
Conditions
Genetic screening for haemoglobin disorders
Circulatory System
Other hereditary haemolytic anaemias
Registration Number
ISRCTN16886710
Lead Sponsor
Record Provided by the NHS R&D 'Time-Limited' National Programme Register - Department of Health (UK)
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
0
Inclusion Criteria

It took place in an area of North London where 29% of residents and 43% of births are in the ethnic groups at risk for haemoglobin disorders (mainly Camden, Islington, Haringey and Enfield). Twenty six of the 93 practices using the services of the Whittington haematology laboratory agreed to take part, and were divided into 13 control and 13 intervention practices.

Exclusion Criteria

Does not meet inclusion criteria

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The main outcome measure was the change in the number of requests for screening tests for haemoglobin disorders made by control and intervention practices in the baseline and intervention years. We also recorded the numbers of requests from the non-participating practices. For the 2 year follow-up trial the main outcome measure was the number of requests for screening tests from each intervention practice in 1997 and 1998.
Secondary Outcome Measures
NameTimeMethod
ot provided at time of registration
© Copyright 2025. All Rights Reserved by MedPath